Seon et al. [28] identified GLP-1 as a potential biomarker for metabolic syndrome, citing its role in enhancing insulin secretion, improving insulin sensitivity, promoting satiety, slowing gastric emptying, and aiding in weight loss [11]. The gene discussed is INS; the disease is metabolic syndrome.